Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Osborn

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Cancer Discovery|October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD ConsortiumAnirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Nature Medicine|January 7, 2022
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiencyAnirban Das, Sumedha Sudhaman, Daniel Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing SurveillanceCarol Durno, Ayse Bahar Ercan, Vanessa Bianchi, et al.
The Lancet. Oncology|March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Cancer Discovery|October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD ConsortiumAnirban Das, Nicholas R Fernandez, Adrian Levine, et al.
Nature Medicine|January 7, 2022
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiencyAnirban Das, Sumedha Sudhaman, Daniel Morgenstern, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing SurveillanceCarol Durno, Ayse Bahar Ercan, Vanessa Bianchi, et al.
The Lancet. Oncology|March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.
Pageof 9